
CareTrust REIT (CTRE) Stock Forecast & Price Target
CareTrust REIT (CTRE) Analyst Ratings
Bulls say
CareTrust REIT is well positioned because its triple-net healthcare lease model produces durable, contractually driven revenue while shifting property-level costs to tenants, supporting stable cash generation and margin visibility. The company has also shown strong capital deployment discipline, completing $1.4 billion of deals YTD and $710 million of new investments in 3Q26, with estimates that these transactions add $0.08/share to FFO and AFFO and lift 2026 FFO to $2.07/share. Confidence is further supported by a $540 million pipeline, improved SNF fundamentals, and stabilizing tenant-credit concerns around ENSG and PACS, which together could enhance valuation and sustain incremental growth.
Bears say
CareTrust REIT is viewed cautiously because its earnings growth is heavily dependent on external SNF, SHOP, and UK care home acquisitions rather than organic growth, leaving results exposed to a more competitive transaction market and compressed cap rates. The outlook is also pressured by regulatory and reimbursement uncertainty, especially the risk of Medicaid cuts, which could weaken operator coverage, stall earnings growth at its 2026 run-rate, and reduce valuation support. Additional concerns include PACS-related headline risk, an unfinished DOJ investigation, and the company’s sensitivity to labor, capital costs, and unpredictable healthcare regulation.
This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.
CareTrust REIT (CTRE) Analyst Forecast & Price Prediction
Start investing in CareTrust REIT (CTRE)
Order type
Buy in
Order amount
Est. shares
0 shares